Large-scale coronavirus vaccine manufacturing begins in Scotland

The UK Government invested in the facility as part of an agreement to secure early access to Valneva’s vaccine by the end of 2021, if it is proven to be safe, effective and suitable. The vaccine candidate is currently in Phase I/II trials.

Department of Health and Social Care